<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04230720</url>
  </required_header>
  <id_info>
    <org_study_id>19-11021101</org_study_id>
    <nct_id>NCT04230720</nct_id>
  </id_info>
  <brief_title>Effect of Artificial Tears on Biometry</brief_title>
  <official_title>Impact of Lubrication With Artificial Tears on Biometry Measurements for Cataract Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Weill Medical College of Cornell University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Weill Medical College of Cornell University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if measurements for cataract surgery are improved
      with use of additional lubrication with artificial tears. The research study is being done to
      optimize measurements and provide patients with the best visual outcomes after cataract
      surgery.
    </textblock>
  </brief_summary>
  <overall_status>Suspended</overall_status>
  <why_stopped>
    Temporarily paused due to COVID-19 and will resume based on guidance of public health
    authorities. This is not a suspension of IRB approval.
  </why_stopped>
  <start_date type="Anticipated">June 2020</start_date>
  <completion_date type="Anticipated">January 2021</completion_date>
  <primary_completion_date type="Anticipated">January 2021</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Baseline in Keratometry Values (K1 and K2)</measure>
    <time_frame>Baseline, Day 14</time_frame>
    <description>The change in keratometry (K) values (K1 and K2) in all subjects</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Baseline in Axis of Astigmatism</measure>
    <time_frame>Baseline, Day 14</time_frame>
    <description>The change in axis of astigmatism in all subjects</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Baseline Calculated Intraocular Lens Power</measure>
    <time_frame>Baseline, Day 14</time_frame>
    <description>The change in intraocular lens power calculation in all subjects</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Keratometry Values (K1 and K2) in Ocular Surface Disease Subjects</measure>
    <time_frame>Baseline, Day 14</time_frame>
    <description>The change in keratometry (K) values (K1 and K2) in a subset of subjects that were positive for ocular surface disease on the American Society of Cataract and Refractive Surgery (ASCRS) modified Standardized Patient Evaluation of Eye Dryness (SPEED2) questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Axis of Astigmatism in Ocular Surface Disease Subjects</measure>
    <time_frame>Baseline, Day 14</time_frame>
    <description>The change in axis of corneal astigmatism in a subset of subjects that were positive for ocular surface disease on the American Society of Cataract and Refractive Surgery (ASCRS) modified Standardized Patient Evaluation of Eye Dryness (SPEED2) questionnaire</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Cataract</condition>
  <arm_group>
    <arm_group_label>Artificial Tears</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>One eye of each participant is randomized to receive Systane Complete artificial tears 4 times a day for 14 days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No Artificial Tears</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>One eye of each participant is randomized to receive no artificial tears for 14 days</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Systane Complete</intervention_name>
    <description>1 drop 4 times a day for 14 days</description>
    <arm_group_label>Artificial Tears</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male or female â‰¥ 18 years of age

          -  Documentation of bilateral age-related senile cataracts diagnosis

        Exclusion Criteria:

          -  Patients currently using regularly scheduled artificial tears. Patients with
             infrequent or irregular use of artificial tears may not be excluded from the study.

          -  Patients using contact lenses.

          -  Patients with any other surface pathology affecting corneal biometric measurements
             determined with slit-lamp examination or medical history.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ashley Brissette, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Weill Cornell Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Weill Cornell Ophthalmology</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10021</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>January 14, 2020</study_first_submitted>
  <study_first_submitted_qc>January 14, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 18, 2020</study_first_posted>
  <last_update_submitted>May 26, 2020</last_update_submitted>
  <last_update_submitted_qc>May 26, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 28, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>biometry measurement</keyword>
  <keyword>artificial tear</keyword>
  <keyword>cataract surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cataract</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

